7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 
      
    		                    
      cash flows from operating activities:
    		                    
      net income
    		-12,585,000 -20,340,000 -25,120,000 -23,113,000 -23,420,000 -33,290,000 -35,731,000 -41,902,000 -39,148,000 -31,424,000 -23,419,000 -13,599,000 -22,511,000 -5,743,000 -20,238,000 -14,851,000 -15,697,000 6,345,000 10,376,000 -11,467,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                    
      depreciation
    		220,000 213,000 220,000 192,000 184,000 139,000 170,000 247,000             
      amortization of intangible assets
    		240,000 240,000 240,000 240,000 100,000 100,000 100,000 100,000             
      amortization of debt-related costs
    		152,000 146,000 139,000  129,000                
      stock-based compensation
    		12,243,000 8,233,000 6,930,000 7,403,000 7,415,000 7,481,000 5,519,000 5,482,000 5,250,000 5,192,000 3,906,000 3,671,000 3,583,000 3,532,000 2,674,000 2,179,000 2,119,000 2,794,000 1,363,000 438,000 
      loss on debt extinguishment
    		   0 0                
      non-cash lease expense
    		205,000 159,000 164,000 173,000 167,000 163,000 132,000 131,000 125,000 134,000 151,000 121,000 117,000 113,000 113,000 116,000     
      net amortization/accretion of marketable securities
    		-1,534,000 -1,709,000 -1,314,000  -1,144,000                
      realized loss on equity investments
    		                    
      change in fair value of equity warrants issued by licensee
    		   0 0 0 201,000 -152,000 36,000 -18,000 17,000 -19,000 18,000        
      unrealized (gain) income from transactions denominated in a foreign currency
    		                    
      changes in operating assets and liabilities:
    		                    
      accounts receivable
    		-14,286,000 4,092,000 -15,666,000 -17,601,000 370,000 356,000 -13,264,000 -11,259,000   -2,500,000  0 0 -17,000   5,000,000 -25,000,000  
      inventory
    		37,000 -1,168,000 -84,000 227,000 -652,000 -692,000 -929,000 -3,092,000             
      other receivables
    		190,000 -179,000 -429,000 -154,000 166,000 165,000 -383,000 -84,000 -762,000 171,000 3,165,000 412,000 -3,392,000 -285,000 -225,000 46,000 18,000 90,000 -227,000 -18,000 
      prepaid expenses
    		7,978,000 -23,174,000 8,725,000 -7,702,000 -1,149,000 767,000 1,065,000 -1,861,000 -793,000 -492,000 257,000 -1,272,000         
      other non-current assets
    		-373,000 102,000 125,000 -42,000 25,000 483,000 106,000 -110,000 -102,000 -544,000 38,000 -140,000 0 -89,000 14,000 497,000 -436,000 -1,071,000 -1,255,000 -48,000 
      accounts payable and other accrued liabilities
    		23,842,000 2,294,000 11,309,000 15,047,000 5,868,000 7,087,000 12,335,000 8,063,000 5,814,000 409,000 -1,046,000 -366,000 1,322,000 -2,104,000 1,969,000 357,000 -1,099,000 -441,000 5,063,000 215,000 
      accrued payroll and benefits
    		1,940,000 1,678,000 -5,890,000 4,498,000 3,280,000 2,087,000 -7,287,000 5,347,000 2,592,000 1,100,000 -1,313,000 1,427,000 1,312,000 975,000 -993,000 552,000 776,000 785,000 -355,000 520,000 
      other long-term liabilities
    		   0 0 -1,000 -232,000 189,000 33,000 -29,000 -8,000 7,000 -3,000 -28,000 -43,000 -35,000 43,000 -16,000 123,000  
      net cash from operating activities
    		18,257,000 -29,387,000 -20,651,000 -22,182,000 -8,652,000 -14,404,000 -37,789,000  -32,362,000 -23,826,000 -21,970,000 -10,874,000 -18,611,000 -4,259,000 -15,286,000 -12,121,000 7,112,000 20,551,000 -11,794,000 -10,013,000 
      capex
    		-1,910,000 -1,001,000 -590,000 -72,000 -282,000 -1,039,000 -174,000  -375,000 -787,000 -340,000 -127,000 -96,000 -122,000 -161,000 -274,000 -121,000 -16,000 -175,000 50,000 
      free cash flows
    		16,347,000 -30,388,000 -21,241,000 -22,254,000 -8,934,000 -15,443,000 -37,963,000  -32,737,000 -24,613,000 -22,310,000 -11,001,000 -18,707,000 -4,381,000 -15,447,000 -12,395,000 6,991,000 20,535,000 -11,969,000 -9,963,000 
      cash flows from investing activities:
    		                    
      proceeds from maturities of marketable securities
    		99,500,000 79,000,000 91,218,000  24,495,000 10,540,000 2,500,000  51,740,000 64,879,000 40,301,000          
      purchases of marketable securities
    		-102,333,000 -129,703,000 -125,570,000 -89,967,000 -21,085,000 -47,026,000 -104,550,000 0 3,000 0 -28,667,000 -92,407,000         
      purchases of long-term investments
    		   0 0                
      purchases of property and equipment
    		-1,910,000 -1,001,000 -590,000 -72,000 -282,000 -1,039,000 -174,000 0 -375,000 -787,000 -340,000 -127,000 -96,000 -122,000 -161,000 -274,000 -121,000 -16,000 -175,000 50,000 
      net cash from investing activities
    		-4,743,000 -51,704,000 -34,942,000 -59,574,000 3,128,000 -40,525,000 -102,224,000 17,850,000 47,368,000 64,092,000 11,294,000          
      cash flows from financing activities:
    		                    
      proceeds from issuance of common stock, net of paid issuance costs
    		0 -354,000 135,125,000 0 -43,000 -274,000 98,604,000              
      proceeds from issuance of pre-funded warrants, net of paid issuance costs
    		   0 0 0 9,365,000              
      proceeds from sale of common stock under employee stock purchase plan
    		0   659,000 0   520,000 0   240,000 0        
      proceeds from exercise of stock options
    		2,562,000 1,205,000 1,437,000                  
      proceeds from long-term debt
    		   0                 
      payments for debt extinguishment
    		   0 0                
      payments of debt issuance costs
    		                    
      net cash from financing activities
    		2,562,000 1,952,000 136,562,000 2,927,000 639,000 42,319,000 108,771,000 19,760,000 104,893,000 510,000 5,013,000 264,000 -136,000 74,734,000 19,125,000 -74,000 75,000 1,000 19,000 91,763,000 
      net increase in cash, cash equivalents and restricted cash
    		16,076,000 -79,139,000 80,969,000             -12,469,000 7,066,000   81,800,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 97,381,000                  
      cash, cash equivalents and restricted cash at end of period
    		16,076,000 -79,139,000 178,350,000                  
      supplemental disclosures from noncash, investing and financing activities:
    		                    
      operating lease right-of-use asset obtained in exchange for operating lease liability
    		   0 0 0 384,000 0 0 1,730,000 116,000     0    0 
      interest expense paid in cash
    		2,116,000 2,094,000 2,074,000 2,174,000 4,152,000 468,000 868,000 846,000 732,000 709,000 593,000          
      additions of intangible assets included within accounts payable and other accrued liabilities
    		                    
      additions of property and equipment included within accounts payable and other accrued liabilities
    		1,155,000 305,000 39,000 41,000 55,000   102,000 11,000            
      offering costs included within accounts payable and other accrued liabilities
    		  354,000                  
      unrealized gain from transactions denominated in a foreign currency
    		         -17,000 16,000 2,000 0 -2,000 1,000 2,000 4,000 27,000 -35,000  
      unrealized loss on equity investments
    		      585,000  111,000 -15,000 65,000          
      amortization/accretion of debt-related costs
    		                    
      net amortization/accretion on marketable securities
    		      -290,000 -125,000 -487,000            
      realized/unrealized gain on equity investments
    		                    
      proceeds from sales and maturities of marketable securities
    		                    
      intangible asset additions
    		       0             
      proceeds from issuance of common stock under an at-the-market sales agreement, net of paid issuance costs
    		                    
      payment of debt issuance costs
    		   0           -815,000      
      payments of deferred offering costs
    		                    
      operating lease modification
    		                    
      realized/unrealized loss on equity investments
    		    0                
      unrealized income from transactions denominated in a foreign currency
    		                    
      proceeds from exercise of equity awards
    		    721,000 1,818,000 802,000  516,000 45,000 13,000          
      net increase in cash and cash equivalents
    		    -4,885,000   -1,725,000 119,899,000 40,776,000 -5,663,000 -97,829,000 -75,874,000        
      cash and cash equivalents — beginning of period
    		    0 0 224,947,000  0 0 71,660,000  0        
      cash and cash equivalents — end of period
    		    -4,885,000 -12,610,000 193,705,000  119,899,000 40,776,000 65,997,000  -75,874,000        
      supplemental disclosures noncash and other investing and financing activities:
    		                    
      offering costs included within accounts payable and accrued liabilities
    		    -121,000 -136,000 275,000              
      proceeds from term loan
    		       0 5,000,000 0 5,000,000 0 0 0 20,000,000      
      payment of term loan issuance costs
    		           0 0        
      supplemental disclosures noncash investing and financing activities:
    		                    
      accretion of term loan-related costs
    		      114,000 111,000 101,000 92,000 81,000 78,000         
      net decrease in cash and cash equivalents
    		      -31,242,000              
      amortization of discount on available-for-sale debt securities
    		          -1,484,000 -1,253,000         
      unrealized (gain) loss on equity investment
    		                    
      net cash from by operating activities
    		                    
      proceeds from sales of marketable securities
    		                    
      proceeds from issuance of common stock upon follow-on public offering, net of paid issuance costs
    		           0 -218,000        
      proceeds from exercise of vested stock options
    		           24,000 82,000   8,000 75,000 1,000 19,000  
      payment of deferred offering costs
    		           0 0 -15,000 -60,000      
      cash and cash equivalents — beginning of year
    		                    
      cash and cash equivalents — end of year
    		                    
      proceeds from issuance of common stock upon follow-on public offerings, net of paid issuance costs
    		                    
      deferred offering costs included within accounts payable and accrued liabilities
    		                    
      depreciation and amortization
    		         182,000 104,000 98,000 94,000 92,000 41,000 40,000 83,000 125,000 64,000 40,000 
      deferred offering costs included within additional-paid in capital
    		                    
      loss on lease termination
    		               0 0 0 2,000  
      loss on disposal of property and equipment
    		               0 0 0 70,000  
      unrealized loss on equity investment
    		           -58,000         
      issuance of common stock upon in-license agreement milestone achievement
    		                    
      stock issued for in-license agreements included within research and development expense
    		                    
      expense of right-of-use asset upon lease termination
    		               0     
      deferred offering costs included in accounts payable and accrued liabilities
    		                    
      cash from investing activities
    		            -57,127,000 -122,000 -161,000 -274,000 -121,000 -16,000 -175,000 50,000 
      "operating lease right-of-use asset" obtained in exchange for operating lease liability
    		                    
      "interest expense" paid in cash
    		            967,000 0 127,000      
      additions of "property and equipment, net" included within "accounts payable and other accrued liabilities"
    		            -15,000 18,000 41,000      
      expensing of "operating lease right-of-use assets" upon lease termination
    		                    
      stock issued for in-license agreements included within "research and development" expense
    		                    
      amortization and accretion of term loan-related costs
    		                    
      prepaid expenses and other current assets
    		             -1,180,000 926,000 -1,380,000 864,000 -1,206,000 -321,000 236,000 
      deferred offering costs included within "additional-paid in capital"
    		                    
      deferred offering costs included within "accounts payable and accrued liabilities"
    		              55,000      
      amortization and accretion of long-term debt related costs
    		              55,000      
      unrealized loss on equity securities
    		              192,000      
      change in fair value of equity warrants
    		              245,000      
      issuance of common stock pursuant to in-license agreement
    		               0 0 0 5,494,000  
      contract asset
    		                  -7,199,000  
      net decrease in cash, cash equivalents and restricted cash
    		              3,678,000    -11,950,000  
      cash, cash equivalents, and restricted cash — beginning of period
    		              171,332,000      
      cash, cash equivalents, and restricted cash — end of period
    		              175,010,000  7,066,000 20,536,000 156,199,000  
      reconciliation of cash, cash equivalents and restricted cash
    		                    
      cash and cash equivalents
    		              175,010,000 -12,469,000 7,066,000 20,556,000 156,179,000 81,800,000 
      restricted cash
    		                  20,000 0 
      cash, cash equivalents and restricted cash
    		              175,010,000 -12,469,000 7,066,000 20,536,000 156,199,000 81,800,000 
      stock issued for in-license agreements
    		                    
      proceeds from issuance of preferred stock, net of issuance costs
    		                    
      proceeds from issuance of common stock upon initial public offering, net of issuance costs
    		                    
      proceeds from stock option exercises prior to vesting
    		                    
      cash, cash equivalents, and restricted cash — beginning of year
    		               0 0 0 168,149,000 0 
      cash, cash equivalents, and restricted cash — end of year
    		                    
      stock issued for license agreements
    		                    
      conversion of preferred stock into common stock upon initial public offering
    		                    
      additions of property and equipment included in accounts payable and other accrued liabilities
    		                    
      change in fair value of derivative assets
    		                346,000    
      issuance costs for initial public offering
    		                    
      stock issued to licensor pursuant to execution of out-license agreement
    		                0 0 5,494,000  
      series c preferred stock issuance costs in accounts payable and other accrued liabilities
    		                    
      amortization of operating lease right-of-use asset
    		                 44,000 43,000 56,000 
      proceeds from issuance of series b preferred stock, net of issuance costs
    		                   0 
      proceeds from exercise of stock options prior to vesting
    		                    
      additions of property and equipment in accounts payable and other accrued liabilities
    		                    
      derecognition of right-of-use asset upon lease termination
    		                 0 -38,000  
      impairment of operating lease right-of-use asset
    		                    
      change in fair value of derivative liabilities
    		                    
      stock issued for in-license agreement
    		                    
      non-cash related party interest expense
    		                    
      loss on extinguishment of convertible notes
    		                    
      proceeds from issuance of series c preferred stock, net of issuance costs
    		                   -244,000 
      proceeds from issuance of convertible notes, net of issuance costs
    		                    
      proceeds from early exercise of stock options
    		                   0 
      proceeds from issuance of common stock upon exercise of vested stock options
    		                    
      conversion of preferred stock to common stock upon initial public offering
    		                    
      settlement of derivative liabilities upon conversion of convertible notes
    		                    
      series b preferred stock issuance costs in accounts payable and other accrued liabilities
    		                    
      conversion of convertible notes to series b preferred stock
    		                    
      convertible notes issuance costs included in accounts payable and accrued liabilities
    		                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.